Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
16.91
0.93 (5.82%)
At close: Aug 15, 2025, 3:59 PM
16.61
-1.75%
After-hours: Aug 15, 2025, 07:30 PM EDT
Arcutis Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -93.27M | -129.72M | -140.04M | -195.53M | -198.76M | -217.42M | -262.14M | -267.88M | -330.82M | -327.23M | -311.46M | -310.76M | -260.04M | -234.64M | -206.36M | -169.08M | -150.3M | -143.71M |
Depreciation & Amortization | 5.43M | 5.37M | 2.6M | 2.53M | 1.48M | 1.52M | 1.52M | 1.48M | 1.38M | 1.15M | 934K | 723K | 557K | 506K | 454K | 353K | 267K | 155K |
Stock-Based Compensation | 39.44M | 41.48M | 41.73M | 41.09M | 41.31M | 39.36M | 38.81M | 39.32M | 38.11M | 35.63M | 32.68M | 29.1M | 25.68M | 21.92M | 23.89M | 20.85M | 17.75M | 15.46M |
Other Working Capital | 32.13M | 35.14M | 43.86M | 38.15M | 19.39M | 8.38M | -3.68M | -9.26M | -1.95M | 2.82M | 4.23M | 13.04M | 12.43M | 13.33M | 3.38M | -10.81M | -12.68M | -9.85M |
Other Non-Cash Items | -25.24M | 9.94M | 30.53M | 45.59M | 60.78M | 39.06M | 17.94M | -125K | 28.48M | 28.13M | 30.3M | 31.62M | 1.99M | 1.32M | 309K | 365K | 426K | 269K |
Deferred Income Tax | n/a | n/a | n/a | -16.33M | -17.86M | -19.69M | -19.69M | -3.36M | -1.82M | n/a | n/a | 885K | 2.04M | 2.84M | 3.45M | 2.99M | 1.86M | 1.07M |
Change in Working Capital | 8.14M | -13.81M | -1.57M | 411K | -18.48M | -19.94M | -23.5M | -31.32M | -20.91M | -18.76M | -10.18M | 10.07M | 18.23M | 22.66M | 3.62M | -10.97M | -18.3M | -11.46M |
Operating Cash Flow | -65.49M | -110.94M | -112.16M | -167.65M | -176.95M | -198.32M | -247.06M | -261.88M | -285.59M | -281.08M | -257.71M | -238.36M | -211.55M | -185.4M | -174.63M | -155.49M | -148.3M | -138.23M |
Capital Expenditures | -5.83M | -5.75M | -5.14M | -149K | -70K | -346K | -428K | -545K | -23.44M | -23.24M | -23.28M | -23.42M | -602K | -565K | -995K | -887K | -860K | -834K |
Cash Acquisitions | n/a | n/a | n/a | 62.18M | 16.57M | -72.83M | -180.66M | -219.89M | -158.83M | -122.08M | -14.24M | -37.2M | -52.65M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -112.36M | -204.98M | -254.82M | -355.6M | -372.29M | -292.13M | -225.84M | -145.75M | -364.92M | -399.55M | -415.39M | -425.54M | -216.38M | -348.01M | -292.51M | -344.01M | -428.22M | -243.82M |
Sales Maturities Of Investments | 277.01M | 280M | 288.78M | 287.51M | 264.89M | 336.25M | 406.5M | 430.91M | 430.16M | 428.05M | 351.47M | 343.06M | 311.81M | 225.93M | 217.55M | 169.55M | 158.55M | 145.15M |
Other Investing Acitivies | -10M | -62.14M | -90.83M | -153.01M | -107.4M | 44.13M | 180.66M | 219.89M | 158.83M | 122.08M | 29.67M | 76.38M | 95.43M | -122.09M | -74.96M | -174.46M | -269.67M | -98.67M |
Investing Cash Flow | 148.83M | 69.27M | 28.82M | -68.24M | -107.47M | 43.78M | 180.23M | 284.62M | 41.81M | 5.25M | -87.2M | -105.9M | 94.83M | -122.65M | -75.95M | -175.34M | -270.53M | -99.5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 1.97M | 649K | 649K | 649K | n/a | n/a | n/a | 12.47M | 12.47M | 12.47M | 12.47M | 842K | 842K | 842K | 842K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -96.56M | -95.17M | -95.48M | 2.32M | 2.79M | 2.4M | 2.42M | 3M | 125.53M | 125.59M | 125.75M | 197.67M | 74.34M | 74.39M | 74.46M | 2.6M | 2.1M | 1.22M |
Financial Cash Flow | -95.24M | -95.17M | 66.2M | 262.9M | 263.38M | 262.99M | 101.32M | 3M | 287.12M | 287.18M | 301.8M | 373.72M | 88.79M | 88.85M | 281.95M | 338.45M | 337.95M | 337.07M |
Net Cash Flow | -11.84M | -136.99M | -17.37M | 27.07M | -21.15M | 108.38M | 34.45M | 25.62M | 43.29M | 11.3M | -43.12M | 29.46M | -27.93M | -219.2M | 31.37M | 7.61M | -80.88M | 99.34M |
Free Cash Flow | -71.32M | -116.69M | -117.3M | -167.8M | -177.02M | -198.66M | -247.49M | -262.42M | -309.03M | -304.32M | -281M | -261.78M | -212.15M | -185.96M | -175.62M | -156.38M | -149.16M | -139.06M |